Blueprint Medicines Corporation (BPMC)
NASDAQ: BPMC · IEX Real-Time Price · USD
114.97
+1.51 (1.33%)
At close: Jul 19, 2024, 4:00 PM
114.91
-0.06 (-0.05%)
Pre-market: Jul 20, 2024, 9:29 AM EDT
Blueprint Medicines Market Cap
Blueprint Medicines has a market cap or net worth of $7.20 billion as of July 22, 2024. Its market cap has increased by 100.16% in one year.
Market Cap
7.20B
Enterprise Value
6.87B
1-Year Change
100.16%
Ranking
Category
Stock Price
$114.97
Market Cap Chart
Since April 30, 2015, Blueprint Medicines's market cap has increased from $469.40M to $7.20B, an increase of 1,433.67%. That is a compound annual growth rate of 34.43%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 19, 2024 | 7.20B | 28.39% |
| Dec 29, 2023 | 5.61B | 113.92% |
| Dec 30, 2022 | 2.62B | -58.41% |
| Dec 31, 2021 | 6.30B | 0.83% |
| Dec 31, 2020 | 6.25B | 58.57% |
| Dec 31, 2019 | 3.94B | 66.35% |
| Dec 31, 2018 | 2.37B | -19.85% |
| Dec 29, 2017 | 2.96B | 285.69% |
| Dec 30, 2016 | 766.50M | 7.38% |
| Dec 31, 2015 | 713.80M | 52.07% |
View and export this data all the way back to 2015.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Cerevel Therapeutics Holdings | 7.82B |
| The Ensign Group | 7.71B |
| Ascendis Pharma | 7.65B |
| Revolution Medicines | 7.61B |
| Penumbra | 7.36B |
| Ionis Pharmaceuticals | 6.98B |
| Repligen | 6.92B |
| Halozyme Therapeutics | 6.88B |